These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17651659)

  • 1. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses.
    Colbourn T; Asseburg C; Bojke L; Philips Z; Claxton K; Ades AE; Gilbert RE
    Health Technol Assess; 2007 Aug; 11(29):1-226, iii. PubMed ID: 17651659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses.
    Colbourn TE; Asseburg C; Bojke L; Philips Z; Welton NJ; Claxton K; Ades AE; Gilbert RE
    BMJ; 2007 Sep; 335(7621):655. PubMed ID: 17848402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
    Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevention of early-onset neonatal group B streptococcal disease.
    Money D; Allen VM;
    J Obstet Gynaecol Can; 2013 Oct; 35(10):939-948. PubMed ID: 24165063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness.
    Daniels J; Gray J; Pattison H; Roberts T; Edwards E; Milner P; Spicer L; King E; Hills RK; Gray R; Buckley L; Magill L; Elliman N; Kaambwa B; Bryan S; Howard R; Thompson P; Khan KS
    Health Technol Assess; 2009 Sep; 13(42):1-154, iii-iv. PubMed ID: 19778493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid intrapartum test for group B Streptococcus to reduce antibiotic usage in mothers with risk factors: the GBS2 cluster RCT.
    Daniels J; Dixon EF; Gill A; Bishop J; D'Amico M; Ahmed K; Dodds J; Tryposkiadis K; Wilks M; Millar M; Husain S; Gray J; Whiley A; Moore PV; Munetsi RL; Hemming K; Roberts T; Plumb J; Deeks J; Khan KS; Thangaratinam S
    Health Technol Assess; 2022 Feb; 26(12):1-82. PubMed ID: 35195519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
    Schrag SJ; Verani JR
    Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness.
    Procter SR; Gonçalves BP; Paul P; Chandna J; Seedat F; Koukounari A; Hutubessy R; Trotter C; Lawn JE; Jit M
    PLoS Med; 2023 Mar; 20(3):e1004068. PubMed ID: 36917564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?
    Oster G; Edelsberg J; Hennegan K; Lewin C; Narasimhan V; Slobod K; Edwards MS; Baker CJ
    Vaccine; 2014 Aug; 32(37):4778-85. PubMed ID: 24992717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
    Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials.
    Tajik P; van der Ham DP; Zafarmand MH; Hof MH; Morris J; Franssen MT; de Groot CJ; Duvekot JJ; Oudijk MA; Willekes C; Bloemenkamp KW; Porath M; Woiski M; Akerboom BM; Sikkema JM; Nij Bijvank B; Mulder AL; Bossuyt PM; Mol BW
    BJOG; 2014 Sep; 121(10):1263-72; discussion 1273. PubMed ID: 24862166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection.
    Stade B; Shah V; Ohlsson A
    Cochrane Database Syst Rev; 2004; (3):CD003520. PubMed ID: 15266490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a cost-effective strategy to prevent neonatal early-onset group B haemolytic streptococcus disease in the Netherlands.
    Kolkman DG; Rijnders ME; Wouters MG; van den Akker-van Marle ME; van der Ploeg CK; de Groot CJ; Fleuren MA
    BMC Pregnancy Childbirth; 2013 Jul; 13():155. PubMed ID: 23899463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics.
    Mohle-Boetani JC; Lieu TA; Ray GT; Escobar G
    Pediatrics; 1999 Apr; 103(4 Pt 1):703-10. PubMed ID: 10103290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease.
    Akker-van Marle ME; Rijnders ME; Dommelen P; Fekkes M; Wouwe JP; Amelink-Verburg MP; Verkerk PH
    BJOG; 2005 Jun; 112(6):820-6. PubMed ID: 15924544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of perinatal infection caused by group B beta-hemolytic streptococcus].
    Bevilacqua G
    Acta Biomed Ateneo Parmense; 1999; 70(5-6):87-94. PubMed ID: 11402819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
    Kim SY; Nguyen C; Russell LB; Tomczyk S; Abdul-Hakeem F; Schrag SJ; Verani JR; Sinha A
    Vaccine; 2017 Oct; 35(45):6238-6247. PubMed ID: 28951085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group B Streptococci Screening Before Repeat Cesarean Delivery: A Cost-Effectiveness Analysis.
    Albright CM; MacGregor C; Sutton D; Theva M; Hughes BL; Werner EF
    Obstet Gynecol; 2017 Jan; 129(1):111-119. PubMed ID: 27926650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
    Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
    Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost Effectiveness of Latest Recommendations for Group B Streptococci Screening in the United States.
    Williams M; Zantow E; Turrentine M
    Obstet Gynecol; 2020 Apr; 135(4):789-798. PubMed ID: 32168204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.